Search results
Results From The WOW.Com Content Network
The biotechnology industry in Boston dates back to the 1970s, when genetic engineering was developing. Biogen was the first company in Boston to focus on biotechnology. [6] [7] In 2008, Massachusetts Governor Deval Patrick announced the Massachusetts Life Sciences Act, promising $1 billion to further the development of the biotech industry.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Valeant Pharmaceuticals: Allergan, Inc: 53.3 69 Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25. [26] 16 2014 Valeant Pharmaceuticals ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Boston Scientific (1 C, 2 P) M. Moderna (1 C, 2 P) Pages in category "Health care companies based in Massachusetts" ... Agios Pharmaceuticals; Alere;
This is a list of companies located in Massachusetts ... Boston Beer Company; Boston Scientific; Brine; C ... Millennium Pharmaceuticals; Moderna; N
In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. [41] As of 2017, the company had revenues of $20.9 billion, and was a Fortune 500 company. [42]